info@millefioriskincare.com
321.821.4778

DAXXIFY

After decades, a new neuromodulator category has arrived. DAXXIFY® is the first and only peptide-powered, FDA-approved frown line treatment with a median duration of 6 months.

Innovative Treatment

Disruptive innovation powered byPeptide Exchange Technology(PXT).2,11Discover the first neuromodulator of its kind in over 20 years.1,2,5-8

DAXXIFY® is What You're Looking For

Conventional frown line treatments last a median of approximately 3-4 months.

Wrinkles and frown lines are some of often the first signs of aging. These lines, usually around the eyes, forehead, and eyebrows are a natural part of aging but they can make you appear more tired and older than you are.  Many people want to reverse this part of the aging process to restore their youthful-looking skin, while some want to stop these wrinkles from forming in the first place.

DAXXIFY® is a Revolutionary Injectable?

That is what Revance’s DAXXIFY®, the newest FDA-approved neuromodulator, achieves for six to nine months. DAXXIFY is a revolutionary injectable that quickly fills frown lines for a youthful appearance without surgery.

DAXXIFY® may last up to twice as long as conventional neuromodulator treatments for some patients.2-9*

 

98% None or mild lines3‡ 

The vast majority of patients achieved wrinkle severity of none or mild at week 4 per investigator’s assessment.3‡

98% achieved ≥2-grade improvement at week 4 per investigator’s assessment.1,3‡ 74% achieved a ≥2-grade improvement at week 4 per both investigator’s and patient’s assessments.1,3‡

Call Us Today for a Consultation!

Millefiori Medical Skin Rejuvenation — Located in Historic Downtown Melbourne

Millefiori Medical Skin Rejuvenation servicing the entire Space Coast area including Melbourne, West Melbourne, Viera, Palm Bay, Daytona, Merritt Island, Satellite Beach, Melbourne Beach, Vero Beach, Cocoa, Cocoa Beach and Titusville.

Formulation Matters

DAXXIFY® is the first and only peptide-powered neuromodulator.1,2,5-8


Peptide Exchange Technology™ (PXT), based on cell-penetrating peptide technology, is our proprietary, synthetic, 35-amino-acid stabilizing excipient peptide with a highly positive charge.1,2,11

PXT enhances the affinity of BoNT/A for cell membranes and anchors BoNT/A to its target, which may enhance internalization.12†

The peptide helps eliminate the need for human serum albumin (HSA).1,2,11

PXT Benefits

  • No Accessory Proteins
  • No human components (including human serum albumin)
  • No Animal Derivatives